• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC BAKRI TAMPONADE BALLOON CATHETER; OQY INTRAUTERINE BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC BAKRI TAMPONADE BALLOON CATHETER; OQY INTRAUTERINE BALLOON Back to Search Results
Model Number G30673
Device Problem Material Rupture (1546)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 08/04/2022
Event Type  Injury  
Event Description
As reported, during treatment of a post-partum hemorrhage, a bakri tamponade balloon catheter ruptured.The patient lost 900ml of blood before the device was inserted and inflated with 400ml saline.The device was not handled by any metal tools.After indwelling for 12 hours, the patient heard a rupture sound followed by an outflow of fluid.The device was immediately removed from the patient.The patient lost 100ml of blood following device placement.As hemostasis was achieved following device removal, no additional intervention was required.The patient did not experience any adverse effects due to this occurrence.
 
Manufacturer Narrative
(b)(6).This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Manufacturer Narrative
Event summary as reported, during treatment of a post-partum hemorrhage, a bakri tamponade balloon catheter ruptured.The patient lost 900ml of blood before the device was inserted and inflated with 400ml saline.The device was not handled by any metal tools.After indwelling for 12 hours, the patient heard a rupture sound followed by an outflow of fluid.The device was immediately removed from the patient.The patient lost 100ml of blood following device placement.As hemostasis was achieved following device removal, no additional intervention was required.The patient did not experience any adverse effects due to this occurrence.Investigation - evaluation reviews of the complaint history, device history record, instructions for use, and quality control procedures were conducted during the investigation.The device was not returned for investigation.A review of complaint history records shows one other related complaint associated with the complaint device lot.Due to the individual nature of the manufacturing and inspection process for the devices in the lots, it is unlikely that these events are an indication of device issue within the entire lot.No related non-conformances were recorded for this lot.The device history record review provides objective evidence that the device was manufactured to specification.A review of relevant manufacturing documents was conducted.It was concluded that the device aspect in question was functionally inspected by quality control and no notable gaps in production or processing controls were noted.There is no indication that a design or process related failure mode contributed to the reported event.Sufficient inspection activities are in place to identify this failure mode prior to distribution.The device is provided with instructions for use which caution, ¿avoid excessive force when inserting the balloon into the uterus.¿ the ifu further warns, "the bakri postpartum balloon is indicated for use in the event of primary postpartum hemorrhage within 24 hours of delivery." based on the available information, cook has concluded that the most probable cause of the reported event could not be determined.Cook will continue monitoring of similar complaints and has notified the appropriate personnel of this event.Per a review of risk documentation, no further action is required.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAKRI TAMPONADE BALLOON CATHETER
Type of Device
OQY INTRAUTERINE BALLOON
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer (Section G)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer Contact
jason crouch
750 daniels way
bloomington, IN 47404
8123392235
MDR Report Key15311936
MDR Text Key298800562
Report Number1820334-2022-01417
Device Sequence Number1
Product Code OQY
UDI-Device Identifier10827002306735
UDI-Public(01)10827002306735(17)240510(10)13950951
Combination Product (y/n)N
PMA/PMN Number
K170622
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/10/2024
Device Model NumberG30673
Device Catalogue NumberJ-SOS-100500
Device Lot Number13950951
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/15/2022
Initial Date FDA Received08/29/2022
Supplement Dates Manufacturer Received09/21/2022
Supplement Dates FDA Received10/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-